Clinical Trial Update: Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating low-dose fat to prevent liver disease in infants with cholestasis and related gastrointestinal disorders was terminated, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis

Drugs mentioned

• Low Dose Fat

Snippet

Sponsor: University of California, Los Angeles | Conditions: Cholestasis | Phase 4 | Status: TERMINATED | Results posted: 2016-06-16